Lawyers call on government to spike Bayer’s slow death compulsory licenses tactics
21 November 2011
Anju Ghangurde
Please Login to read the full article.
21 November 2011
Anju Ghangurde
Please Login to read the full article.
RELATED CONTENT
NEWS
- Pharma sees red as India allows Natco to produce patented Nexavar at 3% of Bayer's price
- Bayer's Nexavar reaches under 1% of Indian patients, claims Natco in compulsory licensing case
- Indian Glivec case rescheduled for July
- 'Shut backdoor to WTO', Indian firms warn, as EU seeks free trade concessions
ANALYSIS
Other Informa Analysis
COMMENT
Other Informa Comment
FEATURES
- Interview: Adimab's Gerngross seeks two sweethearts
- Piramal: regulatory overhaul would help India tackle disease challenges
EVENTS
Today
The Rembrandt Hotel, London
07 June 2012
The Rembrandt Hotel, London
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
